• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

附件包块患者的转诊指南。

Guidelines for referral of the patient with an adnexal mass.

作者信息

Gostout Bobbie S, Brewer Molly A

机构信息

Division of Gynecologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Clin Obstet Gynecol. 2006 Sep;49(3):448-58. doi: 10.1097/00003081-200609000-00005.

DOI:10.1097/00003081-200609000-00005
PMID:16885652
Abstract

Gynecologists have to differentiate between benign and malignant adnexal masses. We review the evidence supporting to the specialty care of a gynecologic oncologist on the basis of the physical examination, imaging studies, family history, and CA 125 determination. We recommend adherence to the ACOG/SGO Joint Opinion guidelines. Specifically, referral to a gynecologic oncologist seems warranted for postmenopausal women with elevated CA 125, nodular or fixed pelvic mass, metastatic disease, ascites, or family history of breast or ovarian cancer. Premenopausal women should be referred if the CA 125 is elevated above 200 U/mL, there is an evidence of metastatic disease or ascites, or strong family history of breast or ovarian cancer.

摘要

妇科医生必须区分附件肿块的良性和恶性。我们根据体格检查、影像学检查、家族史和CA 125测定结果,回顾支持妇科肿瘤学家专科护理的证据。我们建议遵循美国妇产科医师学会/美国妇科肿瘤学会联合意见指南。具体而言,对于CA 125升高、盆腔肿块呈结节状或固定、有转移性疾病、腹水或有乳腺癌或卵巢癌家族史的绝经后妇女,转诊至妇科肿瘤学家处似乎是必要的。如果绝经前妇女的CA 125升高超过200 U/mL、有转移性疾病或腹水的证据,或有强烈的乳腺癌或卵巢癌家族史,则应转诊。

相似文献

1
Guidelines for referral of the patient with an adnexal mass.附件包块患者的转诊指南。
Clin Obstet Gynecol. 2006 Sep;49(3):448-58. doi: 10.1097/00003081-200609000-00005.
2
How relevant are ACOG and SGO guidelines for referral of adnexal mass?美国妇产科医师学会(ACOG)和妇科肿瘤学会(SGO)关于附件包块转诊的指南相关性如何?
Obstet Gynecol. 2007 Oct;110(4):841-8. doi: 10.1097/01.AOG.0000267198.25223.bc.
3
Validation of referral guidelines for women with pelvic masses.盆腔肿块女性转诊指南的验证
Obstet Gynecol. 2005 Jan;105(1):35-41. doi: 10.1097/01.AOG.0000149159.69560.ef.
4
Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.改良版美国妇产科医师学会/美国妇科肿瘤学会附件包块转诊标准在资源有限环境中的适用性。
Int J Gynaecol Obstet. 2017 Jan;136(1):53-57. doi: 10.1002/ijgo.12006. Epub 2016 Nov 3.
5
Diagnosis and Management of Adnexal Masses.附件肿物的诊断与管理
Am Fam Physician. 2016 Apr 15;93(8):676-81.
6
Adnexal mass in the postmenopausal patient.绝经后患者的附件包块。
Clin Obstet Gynecol. 2015 Mar;58(1):53-65. doi: 10.1097/GRF.0000000000000085.
7
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.遵循实践指南与减少卵巢癌患者的转诊时间有关。
Am J Obstet Gynecol. 2018 Apr;218(4):436.e1-436.e7. doi: 10.1016/j.ajog.2018.01.015. Epub 2018 Jan 17.
8
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.多因素指数检测对美国妇产科医师学会卵巢肿瘤转诊指南的效能评估。
Obstet Gynecol. 2011 Jun;117(6):1298-1306. doi: 10.1097/AOG.0b013e31821b1d80.
9
Initial evaluation and referral guidelines for management of pelvic/ovarian masses.盆腔/卵巢肿块管理的初始评估与转诊指南
J Obstet Gynaecol Can. 2009 Jul;31(7):668-80. doi: 10.1016/s1701-2163(16)34254-2.
10
Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.人附睾蛋白 4 在鉴别绝经前女性附件包块的良恶性方面具有更高的特异性。
Am J Obstet Gynecol. 2011 Oct;205(4):358.e1-6. doi: 10.1016/j.ajog.2011.05.017. Epub 2011 May 14.

引用本文的文献

1
Primary ovarian lymphoma: A case report.原发性卵巢淋巴瘤:一例报告。
Gynecol Oncol Rep. 2023 May 26;47:101212. doi: 10.1016/j.gore.2023.101212. eCollection 2023 Jun.
2
Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.糖基化的生物信息学应用洞察:促使人们开始应用糖组学资源进行癌症诊断和治疗。
Int J Mol Sci. 2020 Dec 8;21(24):9336. doi: 10.3390/ijms21249336.
3
Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass.
基于卵巢肿物临床表现转诊至妇科肿瘤学家的准确性。
Diagnostics (Basel). 2020 Feb 16;10(2):106. doi: 10.3390/diagnostics10020106.
4
Glycosylation Changes in Brain Cancer.脑癌中的糖基化改变。
ACS Chem Neurosci. 2018 Jan 17;9(1):51-72. doi: 10.1021/acschemneuro.7b00271. Epub 2017 Nov 7.
5
Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer.用于发现胃肠道癌靶点的糖组学方法
Front Oncol. 2016 Mar 9;6:55. doi: 10.3389/fonc.2016.00055. eCollection 2016.
6
Criteria for selection of laparoscopy for women with adnexal mass.附件包块女性腹腔镜检查的选择标准。
JSLS. 2014 Jul-Sep;18(3). doi: 10.4293/JSLS.2014.00215.
7
Aberrant glycosylation as biomarker for cancer: focus on CD43.异常糖基化作为癌症生物标志物:聚焦于CD43
Biomed Res Int. 2014;2014:742831. doi: 10.1155/2014/742831. Epub 2014 Feb 13.
8
Multianalyte assay systems in the differential diagnosis of ovarian cancer.多分析物检测系统在卵巢癌鉴别诊断中的应用
Expert Opin Med Diagn. 2012 Mar;6(2):131-138. doi: 10.1517/17530059.2012.661711.
9
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.用于鉴别附件包块患者良恶性病例的血清生物标志物组合。
Gynecol Oncol. 2010 Jun;117(3):440-5. doi: 10.1016/j.ygyno.2010.02.005. Epub 2010 Mar 24.